Cargando…
Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation
The current treatment paradigm for atrial fibrillation (AF) prioritizes rate control over rhythm control; however, rhythm control has shown benefits over other AF strategies. This study compares the outcomes of rivaroxaban with and without concomitant antiarrhythmic drugs (AADs), using propensity sc...
Autores principales: | Chiou, Wei-Ru, Lin, Po-Lin, Huang, Chun-Che, Chuang, Jen-Yu, Liu, Lawrence Yu-Min, Su, Min-I, Liao, Feng-Ching, Kuo, Jen-Yuan, Tsai, Cheng-Ting, Wu, Yih-Jer, Wang, Kuang-Te, Lee, Ying-Hsiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904581/ https://www.ncbi.nlm.nih.gov/pubmed/35260615 http://dx.doi.org/10.1038/s41598-022-07466-z |
Ejemplares similares
-
Author Correction: Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation
por: Chiou, Wei-Ru, et al.
Publicado: (2023) -
Exploratory Evaluation of Rhythm Control by Dronedarone in Combination With Low-Dose Rivaroxaban, Warfarin, Antiplatelet, or None of the Antithrombotic Therapy in High-Risk Patients With Non-Permanent Atrial Fibrillation: A Retrospective Cohort Study
por: Lin, Po-Lin, et al.
Publicado: (2021) -
Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation
por: Chiou, Wei-Ru, et al.
Publicado: (2023) -
Nomogram to predict permanent stoma in rectal cancer patients after sphincter-saving surgery
por: Kuo, Chih-Yu, et al.
Publicado: (2022) -
The Effects of Catheter Ablation on Permanent Pacemakers and Implantable Cardiac Defibrillators
por: Darrat, Yousef H., et al.
Publicado: (2017)